Sep. 18, 2021

basmisanil

CNS-pen. GABAA-α5 neg. allo. mod. (NAM) Ph. II for Down syndrome (240 mg BID) from 56k cmpd competition binding HTS Sci. Rep., Apr. 8, 2021 Roche Innovation Center, Basel, CH

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in